-+ 0.00%
-+ 0.00%
-+ 0.00%

GT Biopharma Q2 EPS $(0.12) Misses $(0.08) Estimate

Benzinga·08/14/2026 12:29:56
Listen to the news
GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.08) by 50 percent. This is a 78.18 percent increase over losses of $(0.55) per share from the same period last year.